Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic
Pedro Nascimento de Lima(RAND Corporation), Carolyn M. Rutter(Fred Hutch Cancer Center), Rosita van den Puttelaar(Erasmus MC), Ann G. Zauber(Memorial Sloan Kettering Cancer Center), Anne I. Hahn(Memorial Sloan Kettering Cancer Center), Jonathan Ozik(Argonne National Laboratory), Iris Lansdorp‐Vogelaar, Nicholson Collier(Argonne National Laboratory), Matthias Harlass(Erasmus MC)
Cited by 21
Related Papers
Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations
|Gastroenterology|2017|193
Quality of Life and Symptom Control after Stent Placement or Surgical Palliation of Malignant Colorectal Obstruction
|Journal of the American College of Surgeons|2009|91
Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision
|Gastroenterology|2024|62
Review-aggregated aspect-based sentiment analysis with ontology features
|Progress in Artificial Intelligence|2018|40
Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis
|Cancer Epidemiology Biomarkers & Prevention|2022|29